News | MRI Breast | February 10, 2017

New Rapid Breast MRI Screening Method Improves Cancer Detection in Dense Breast Tissue

New method cuts screening time to 7 minutes while increasing early detection rates

Rapid Breast MRI, breast cancer screening, David Strahle, RMI, Breast Cancer Research and Treatment study

February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives by detecting breast cancer four to six years earlier than mammographic technology.

Due to its cost, breast imaging using magnetic resonance imaging (MRI) is recommended only for women at high risk for cancer — an estimated 2 percent of women. Mammograms are the current standard for the rest of the population.

The new Rapid Breast MRI protocol — derived from original research by David A. Strahle, M.D., chairman of Regional Medical Imaging in Flint, Mich. — cuts scan time by 70 percent to only 7 minutes, significantly reducing costs and enabling its use for screening women with dense breasts. In conjunction with a local HMO, Strahle found that early detection would have major costs savings for both women and insurance companies when considering the 10 categories of expense dealing with breast cancer.

Mammographic technology for women with dense breast tissue is simply not as effective as MRI in spotting cancer, Strahle noted. In addition, unlike tomosynthesis (3-D mammography) or mammograms, MRIs do not use X-ray radiation.

“It’s like trying to see a thunderstorm through clouds without radar,” Strahle said. “MRI sees through the dense tissue, allowing radiologists to spot virtually all suspicious tumors.”

The new MRI protocol allows screening of women on a regular basis who have dense breast tissue. Strahle conducted peer-reviewed research of 671 women over seven years, which was published on Jan. 30, 2017. The research also includes an easier method for radiologists to read the exams, greatly lowering the false positive rate to below that of any other breast screening method.

Although insurance providers do not yet cover Rapid Breast MRI, the exam costs $395 out-of-pocket at RMI, compared with a diagnostic MRI that runs $700 or more. In addition to reducing scan time, screening Rapid Breast MRI can potentially be conducted every other year, instead of yearly as with mammograms. This equates to an annual cost of only $198, less than the average breast screening costs of $252 in mid-Michigan, Strahle said.

Breast cancer continues to be a leading cause of death in women. About one in eight women will develop breast cancer in their lifetimes, with 85 percent of those cancers occurring in women with no family history, according to breastcancer.org.

The research was published Jan. 30 in the journal Breast Cancer Research and Treatment.

For more information: www.link.springer.com/journal/10549

References

Strahle, D.A., Pathak, D.R., Sierra, A., Saha, S., et al. "Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging," Breast Cancer Research and Treatment. Published online Jan. 30, 2017. DOI: 10.1007/s10549-017-4112-0

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...